RecruitingNot ApplicableNCT06414083

Histologic Comparison of Ablative Techniques for Endometriosis

Histologic Comparison of Ablative Techniques for Endometriosis - a Randomized Trial


Sponsor

TriHealth Inc.

Enrollment

141 participants

Start Date

May 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Argon Beam Coagulator, a medical device called CO2 Laser, and others for people with endometriosis, endometriosis pelvic, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDiathermy

Diathermy will be used to ablate the randomized sample.

DEVICECO2 Laser

CO2 Laser will be used to ablate the randomized sample.

DEVICEArgon Beam Coagulator

Argon Beam Coagulator will be used to ablate the randomized sample.


Locations(1)

Good Samaritan Hospital

Cincinnati, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06414083


Related Trials